Recall Register

Food, drugs, devices › The Binding Site Group, Ltd.

Device recall: Freelite Human Lambda Free Kit (for use on the SPAPLUS) REF LK018.S Freelite Human Lambda Free Kit (for use on the SPAPL

FDA enforcement event 88921 · Class II · initiated 15 Oct 2021 · status Terminated · terminated 4 Feb 2025

DeviceVoluntary: Firm initiated1 product record

FDA enforcement event 88921 is a device recall by The Binding Site Group, Ltd. of Birmingham, initiated 15 Oct 2021 and classified Class II, with 1 product record.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 89% of the 900 device enforcement events initiated in 2021 carry the same class.

Status: Terminated, terminated 4 Feb 2025. Initiation: voluntary: firm initiated. The Binding Site Group, Ltd. has 23 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

The Binding Site Group, Ltd., Birmingham, United Kingdom.

Reason for recall

"Due to calibration curves producing a higher activity than routinely expected and that there may be a decrease in separation between calibrator point 5 and calibrator point 6, which can be exacerbated with calibrator 6 activity reaches the optical ceiling of the SPA+ analyzer."

Distribution

"U.S.: CA, CO, FL, IL, IN, KY, LA, MI, NY, OK, SD, TX and VA. O.U.S.: Canada"

Product records

Recall numberProductQuantityClassStatusReport date
Z-0274-2022Freelite Human Lambda Free Kit (for use on the SPAPLUS) REF LK018.S Freelite Human Lambda Free Kit (for use on the SPAPLUS) (x10) REF LK018.10S2,254 kitsClass IITerminated1 Dec 2021

Context

89%of 2021 device events are Class II900 events that year
1product record in this eventfirm median: 1
23events on this register for the firm

Other enforcement events for The Binding Site Group, Ltd.

InitiatedProduct (first record)TypeClassRecords
16 Apr 2026Brand Name: EXENT Analyser Product Name: EXENT Analyser Model/Catalog Number: IE800.A Software Version: 1.0.20 Product DDeviceClass II1
20 May 2021FREELITE Human Kappa Free Kit for use on the Roche cobas c Systems, Kappa Freie Leichtkette (Human) kit for Roche cobas DeviceClass II1
18 Nov 2020Optilite Freelite Mx Kappa Free Kit REF LK016.M.OPT.ADeviceClass II1
9 Apr 2020The Optilite Clinical Chemistry Analyzer. IVD. Model Number: IE700. UDI-05051700017176 - Product Usage: The Optilite CliDeviceClass II1
6 Nov 2019Rheumatoid Factor (RF) Kit for use on SPAPLUS, for in-vitro diagnostic use, Product code: LK151.S.A. , UDI: 050517000183DeviceClass II1
7 Oct 2019Optilite Optilite Rheumatoid Factor Kit, Ref: LK151.OPT.A, IVD, Rx Only, UDI: 05051700020015 (kit ea. containing four coDeviceClass II1
29 Jul 2019OPTILITE IgM Kit, REF: NK012.OPT.A, IVD, UDI: 05051700017565DeviceClass II1
25 Apr 2019C-Reactive Protein Kit for use on the SPAplus, REF NK044.S.A, Rx only, UDI (01)05051700018456,DeviceClass II1
19 Feb 2019Optilite C-Reactive Protein Kit - Product Usage: The Optilite C-Reactive Protein Reagent is intended for the quantitativDeviceClass II1
6 Nov 2018Binding Site Human IgM Kit (for SPAPLUS), REF: NK012.S The device consists of reaction buffer, sheep anti-IgM antiserum,DeviceClass II1

All 23 events for The Binding Site Group, Ltd.

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Due to calibration curves producing a higher activity than routinely expected and that there may be a decrease in separation between calibrator point 5 and calibrator point 6, which can be exacerbated with calibrator 6 activity reaches the optical ceiling of the SPA+ analyzer."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "U.S.: CA, CO, FL, IL, IN, KY, LA, MI, NY, OK, SD, TX and VA. O.U.S.: Canada"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 4 Feb 2025. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.